Skip to content
Cell Supply
Products
Ncyte® vCardiomyocytes
Ncyte® aCardiomyocytes
Ncyte® Astrocytes
Ncyte® Neural Mix
Ncyte® Endothelial Cells
Ncyte® Smooth Muscle Cells
Upcoming products
Custom Supply
iPSC generation, differentiation and expansion
Discovery Services
Solutions
Ready-to-Use Assays
Custom Screening Services
Overview Assay Capabilities
Modalities
Small Molecule
RNA Therapy
Gene Therapy
Biologics
Regenerative Medicine
Our Approach
iPSC Technology
Insights
Resources
Webinars
News
Events
About
Company
Team
Careers
Contact
Search
Cell Supply
Products
Ncyte® vCardiomyocytes
Ncyte® aCardiomyocytes
Ncyte® Astrocytes
Ncyte® Neural Mix
Ncyte® Endothelial Cells
Ncyte® Smooth Muscle Cells
Upcoming products
Custom Supply
iPSC generation, differentiation and expansion
Discovery Services
Solutions
Ready-to-Use Assays
Custom Screening Services
Overview Assay Capabilities
Modalities
Small Molecule
RNA Therapy
Gene Therapy
Biologics
Regenerative Medicine
Our Approach
iPSC Technology
Insights
Resources
Webinars
News
Events
About
Company
Team
Careers
Contact
Search
Search
HOME
insights
news
author
neurizon therapeutics limited
Ncardia News
Stay up-to-date with the latest news, trends and developments in iPSCs.
Filter
All
News
Press Release
press release
November 19, 2024
Press release: Neurizon's NUZ-001 Reduces Aggregation of Key ALS Disease Target TDP-43 in Preclinical Study
Neurizon Therapeutics Limited
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
